Opendata, web and dolomites
H2020 projects about "regimen"
The page lists 33 projects related to the topic "regimen".
| # | |||
|---|---|---|---|
| 1 | BIOCYCLE | BIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease | 2015 |
| 2 | GlioVac | Validation of a conceptually new treatment for glioblastoma multiforme with an IP protected small molecule | 2015 |
| 3 | PAL | Personal Assistant for healthy Lifestyle (PAL) | 2015 |
| 4 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
| 5 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 6 | AVATAR | Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment | 2015 |
| 7 | PanaMast | Development of non-antibiotic therapy for the treatment of bovine mastitis | 2015 |
| 8 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 9 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 10 | GutBCells | Cellular Dynamics of Intestinal Antibody-Mediated Immune Response | 2016 |
| 11 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 12 | GLAUrious | External Automatic Glaucoma Laser (EAGLE) for the first-line glaucoma treatment: Commercial prototype development and validation | 2016 |
| 13 | GlucoTab | A Novel ICT Assistant Solution for de-Risked Management of Insulin Dosing and Blood Glucose Levels in Hospitalized Patients with Type 2 Diabetes | 2016 |
| 14 | Oncosmart | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2016 |
| 15 | anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept | 2017 |
| 16 | AMPK-DIAB | A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novelinnovative drug for the treatment of type 2 diabetes | 2016 |
| 17 | EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847 | 2014 |
| 18 | EBOVAC1 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 | 2014 |
| 19 | KWatch Glucose | K'Watch Glucose: A ground-breaking biometric wearable for painless, minimally invasive and blood-free glucose monitoring. | 2017 |
| 20 | MicroCaT | Micro-tumor Guided Cancer Therapy Selection MicroCaT | 2018 |
| 21 | CXCR4THERAPY | IMPROVING HEMATOPOIETIC STEM CELL- BASED GENE THERAPY OUTCOME BY MODULATING CXCR4 EXPRESSION | 2018 |
| 22 | EyeTREAT | Innovative tool for personalized treatment of patients with neovascular age-macular degeneration: dosage optimization for long term efficacy treatment | 2018 |
| 23 | EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure | 2018 |
| 24 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 25 | MegaALS | Unravelling the Interplay between Metabolism, Gut Microbiome and Adaptive Immunity in Amyotrophic Lateral Sclerosis | 2018 |
| 26 | FTHPC | Fault Tolerant High Performance Computing | 2019 |
| 27 | RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors | 2019 |
| 28 | RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs | 2019 |
| 29 | TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | 2019 |
| 30 | ImOPac | GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment | 2019 |
| 31 | SMA-TB | A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. | 2020 |
| 32 | PREMSTEM | Brain injury in the premature born infant: stem cell regeneration research network | 2020 |
| 33 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |